PFIZER — Pfizer

Download Report (XLSX)
Quick Nav PFIZER Overview ← Screener
PFIZER · NSE
Pfizer
Pharmaceuticals NSE Equity Data: 01 Jul 2026
₹4,473.60
+₹34.18 (+0.77%)
52W High₹5,540.06
52W Low₹4,360.23
Avg Vol (20D)0.37L
RSI 1444.5
Vol Ratio0.59×
ATR 14₹90.9
5D Change-0.75%
📊 Analysis: PFIZER closed at ₹5,351.50 today, up 0%. RSI at 44.5 — below midpoint, momentum is weak. Price is 10.2% above its 200-day EMA (₹4,855.87) — long-term trend is up. Volume was below average (0.59×) — low participation, move may not sustain. Average daily range (ATR14) is ₹90.9 (1.7% of price) — useful for setting stop loss levels.
Price History — 365 trading days
Daily · NSE

Technical Conditions — 01 Jul 2026

MACD > Signal Line
MACD line crossed above signal line
NR4 Narrow Range
Narrowest price range in 4 sessions
BB Squeeze
Bollinger Bands compressed — volatility breakout likely
Near 52W Low
2.6% from 52-week low
Below EMA200
Price below 200-day EMA — long-term downtrend

Technical Indicators

Momentum
RSI (14)
44.5
Neutral
MACD
-47.7652
Signal: -49.9009
MACD Histogram
2.1357
Bullish momentum
1D Change
+0.77%
5D Change
-0.75%
Volume Ratio
0.59×
Normal
Trend — EMA Levels
EMA 20
₹4,505.11
↓ Price below
EMA 50
₹4,597.05
↓ Price below
EMA 200
₹4,855.87
↓ Long-term downtrend
vs EMA 50
-2.69%
vs EMA 200
-7.87%
EMA Alignment
Bearish Stack
Volatility — Bollinger Bands
BB Upper
₹4,592.66
BB Mid (SMA20)
₹4,495.67
BB Lower
₹4,398.68
BB Width
0.0431
⚠ Squeeze — breakout likely
ATR (14)
₹90.9
Daily range average
ATR % of Price
2%
Stop loss guide
Price Levels
52W High
₹5,540.06
At 52W high
52W Low
₹4,360.23
+2.6% above
From 52W High
-19.25%
NR7
No
Narrow range 7-day
NR4
Yes
Narrow range 4-day
Price > 20D High
No

30-Day Indicator History

Date Close RSI 1D % Vol × Conditions
01 Jul ₹4,473.60 44.5 +0.77% 0.6× MACD↑
30 Jun ₹4,439.40 40.8 +0.78% 0.5×
29 Jun ₹4,404.90 36.9 -1.25% 3.3× VOL
26 Jun ₹4,460.70 41 +0% 0.5×
25 Jun ₹4,460.70 41 -1.03% 0.5×
24 Jun ₹4,507.20 44.5 +0.23% 0.4×
23 Jun ₹4,497.00 43.5 +0.76%
22 Jun ₹4,463.30 40.2 -1.55% 1.9×
19 Jun ₹4,533.70 45.4 -0.12% 0.7×
18 Jun ₹4,539.30 45.8 +1.02% 0.7×
17 Jun ₹4,493.50 41.6 -0.21% 0.5×
16 Jun ₹4,503.10 42.2 -0.33% 0.6×
12 Jun ₹4,509.20 42.4 -1.39% 0.5×
11 Jun ₹4,572.90 46.4 +0.77% 1.2× MACD↑
10 Jun ₹4,537.80 43.7 -1.19% 0.4×
09 Jun ₹4,592.50 47.1 +1.43% 0.6×
08 Jun ₹4,527.90 42.2 +1.61% VOL
05 Jun ₹4,456.30 36 +0.77% 1.1×
04 Jun ₹4,422.40 32.9 -0.97% 0.9×
03 Jun ₹4,465.50 34.9 -1.09% 0.7×
02 Jun ₹4,514.50 37.3 -0.02% 0.5×
01 Jun ₹4,515.30 37.4 -1.81% 0.7×
29 May ₹4,598.50 41.6 -0.52% 0.7×
28 May ₹4,622.60 42.9 +0% 0.5×
27 May ₹4,622.60 42.9 -0.41% 0.6×
26 May ₹4,641.80 43.9 -1.01% 0.6×
25 May ₹4,689.20 46.2 +0.39% 0.5×
22 May ₹4,670.80 45.1 +0.42% 0.9×
21 May ₹4,651.30 44.1 -0.77% 1.1×
20 May ₹4,687.60 45.6 -2.04% 1.5×

Sector Peers — Pharmaceuticals

Symbol Price 1D % RSI Vol × EMA50
BIOCON
Biocon
₹418.20 -0.02% 54.2 1.9× ↑ Above View →
ABBOTINDIA
Abbott India
₹25,550.00 +0.43% 40.1 1.8× ↓ Below View →
DIVISLAB
Divi's Laboratories
₹6,545.50 -0.51% 42.1 0.9× ↓ Below View →
ALKEM
Alkem Laboratories
₹5,567.50 -0.04% 67.4 0.9× ↑ Above View →
DRREDDY
Dr. Reddys Laboratories
₹1,339.90 -1.27% 59.7 0.8× ↑ Above View →
SUNPHARMA
Sun Pharmaceutical
₹1,866.20 +0.2% 61.4 0.6× ↑ Above View →
LUPIN
Lupin
₹2,397.50 -0.89% 63.8 0.6× ↑ Above View →
CIPLA
Cipla
₹1,456.70 -0.59% 66.8 0.4× ↑ Above View →

Want to backtest a strategy on PFIZER?

Choose from 443 pre-built NSE strategies and see historical results in 60 seconds.

Sign Up Free →

We use cookies to keep you signed in and understand how the platform is used. See our Privacy Policy.

Still there?

Here's something you might like

or

One email a week. No spam, unsubscribe anytime.

SEBI Compliance Disclaimer

MomentumIQ is an educational platform for strategy research and backtesting. We do not provide investment advice, recommendations, or tips. All backtest results are hypothetical, based on historical data, and for educational purposes only. Past performance is not indicative of future results. Backtested results may not account for brokerage, slippage, taxes, or other real-world costs. Please consult a SEBI-registered investment advisor before making any investment decisions.